Join the Weight Loss (Obesity / Overweight) group to help and get support from people like you.
Weight Loss (Obesity / Overweight) News (Page 10)
Related terms: Weight Gain, Overweight, Weightloss, Anorexiants, Obesity, Obese, Weight Loss, Loose Weight, Lost Weight, diet drugs, diet medications, anti-obesity medications, Weight Loss Medications
Senators Call on FDA to Act Against Misleading Weight-Loss Drug Commercials
WEDNESDAY, Feb. 12, 2025 – Commercials run by the telehealth company Hims & Hers have been placed under the microscope as lawmakers are calling out advertisement of prescription of injectable...
More Evidence Ozempic Can Curb Alcoholism
WEDNESDAY, Feb. 12, 2025 – Yet another study is supporting the notion that the blockbuster GLP-1 drug Ozempic can help problems drinkers curb their intake. The research found that, compared to...
Study Identifies Some Modifiable Risk Factors for Ovarian Cancer
TUESDAY, Feb. 11, 2025 – Some risk factors for epithelial ovarian cancer are modifiable, according to a study published online Jan. 6 in the International Journal of Gynecological Cancer. Iqbal...
GLP-1 Meds Can Work Wonders for Kidney Health
TUESDAY, Feb. 11, 2025 – Ozempic, Wegovy, Saxenda, Trulicity: These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new research shows....
Body Weight Cycling Tied to Increased Risk for Renal Events in Type 1 Diabetes
MONDAY, Feb. 10, 2025 – For individuals with type 1 diabetes, intraindividual body weight variability, or body weight cycling, is associated with an increased risk for renal events, according to a...
Can GLP-1 Meds Harm Your Eyes?
MONDAY, Feb. 10, 2025 – Yes, rare cases of vision issues have arisen in people taking popular GLP-1 weight loss drugs, but the jury's out on whether the medications caused the eye trouble, according...
New Facial Plastic Surgery Survey Illustrates Impact of GLP-1 Receptor Agonists
FRIDAY, Feb. 7, 2025 – Glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications for weight loss are significantly transforming the field of facial plastic surgery, according to the results of...
Weight Gain Common in Young Women After Breast Reduction Surgery
THURSDAY, Feb. 6, 2025 – Many young women gain weight in the years after breast reduction surgery, according to a study published online in the February issue of Plastic and Reconstructive Surgery....
Breast Reduction Can Spur Weight Gain in Young Women
THURSDAY, Feb. 6, 2025 – Many women may opt for a breast reduction if they encounter issues such as recurrent neck, back and shoulder pain. However, a new study suggests a link between these ...
Prescriptions for Obesity Management Drugs Increasing
THURSDAY, Feb. 6, 2025 – Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with online search trends, according to a study published online...
Diabetic 'Yo-yo' Dieting Can Harm Kidneys
WEDNESDAY, Feb. 5, 2025 – “Yo-yo” dieting – repeatedly losing and gaining weight – can significantly increase risk of kidney disease among people with type 1 diabetes, a new study warns. Diabetics ...
Ultraprocessed Food Consumption in Early Childhood Tied to Obesity
WEDNESDAY, Feb. 5, 2025 – High ultraprocessed food (UPF) consumption during early childhood is associated with obesity development, primarily in males, according to a study published online Jan. 31...
Ultra-Processed Foods Make Up Nearly Half of Calories for Canadian Kids
TUESDAY, Feb. 4, 2025 – Canadian youngsters are munching loads of ultra-processed foods, increasing their lifelong risk of obesity, a new study says. “We saw that ultra-processed foods contributed t...
Metabolic Surgery May Be Beneficial in MASH-Related Cirrhosis, Obesity
MONDAY, Feb. 3, 2025 – For patients with compensated metabolic dysfunction-associated steatohepatitis (MASH)-related cirrhosis and obesity, metabolic surgery is associated with a lower risk for...
Weight-Loss Surgery Protects Liver Health
THURSDAY, Jan. 30, 2025 – Weight-loss surgery can protect the liver health of patients with obesity and fatty liver disease, a new study reports. Patients had a 72% lower risk of developing serious...
Further information
Related drug support groups
bupropion, phentermine, Contrave, Ozempic, amphetamine, Saxenda, methamphetamine, Mounjaro, topiramate, view more... Wegovy, semaglutide, methylphenidate, Qsymia, Zepbound, liraglutide, tirzepatide, Adipex-P, Alli, orlistat, dulaglutide, garcinia cambogia, desvenlafaxine